You are here

Newsletters: 2020

Newsletter

Fall 2020

September 23, 2020
CEO Roundtable on Cancer

We are grateful to all who participated in the CEO Roundtable on Cancer Vision 2020 Annual Meeting and Conference. It was a vibrant and collaborative forum that helped progress...

October 23, 2020
Life Sciences Consortium

Merck KGaA, Darmstadt, Germany, operating under the name EMD Serono in the US and Canada, has been honored with the 2020 Dr. Charles A. Sanders Award ...

October 28, 2020
CEO Roundtable on Cancer

At our Vision 2020 Annual Conference and Meeting, our Founding CEO Bob Ingram shared that the U.S. President’s Cancer Panel on which he is a member is looking closely at “Improving Resilience and...

September 23, 2020
Gold Standard

The CEO Roundtable on Cancer Board of Directors approved a refresh of the CEO Cancer Gold Standard™, its employer-led health and wellness accreditation program, at a September meeting.

One...

October 07, 2020
Project Data Sphere

Experts from the U.S. Food and Drug Administration (FDA), industry, and academia convened on October 7 for a virtual symposium on Rare Cancer Registries. Dr. Julia Beaver, Chief of Medical...

August 17, 2020
CEO Roundtable on Cancer

Welcome to our newest member, Alphanumeric Systems, and their Chief Executive Officer Randy Trice!

Alphanumeric helps life science companies improve the HCP, patient, and employee...

August 25, 2020
Gold Standard

Huntsman Cancer Institute (HCI) at the University of Utah has earned CEO Cancer Gold StandardTM accreditation for its work to reduce the risk of cancer for its employees and covered family members...

October 16, 2020
Gold Standard

High Point University has earned CEO Cancer Gold StandardTM accreditation by the CEO Roundtable on Cancer for its commitment to the health of its employees.

"Here at HPU, we place a high...

October 16, 2020
Gold Standard

The CEO Roundtable on Cancer has accredited Memorial Hermann Health System in Houston, Texas with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its...

Summer 2020

Project Data Sphere
July 14, 2020
Project Data Sphere

Are registries the key to advancing treatment of rare cancers?  We hope to find answers to that question and to identify obstacles blocking the promise of registries and solutions to overcome...

CEO Cancer Gold Standard
July 14, 2020
Gold Standard

Work is progressing to update the Five Pillars of the CEO Cancer Gold Standard™, the employer-led health and wellness accreditation program of the CEO Roundtable on Cancer. Key changes identified...

CEO Cancer Gold Standard 10 Year Accreditation
May 20, 2020
Gold Standard

Eighteen employers are celebrating their ten-year anniversary as CEO Cancer Gold Standard employers, an exceptional accomplishment and testament to their strong commitment to the health of their...

Bristol Myers Squibb
July 14, 2020
Gold Standard

Global biopharmaceutical company Bristol Myers Squibb, based in Princeton, NJ, has earned the prestigious Global CEO Cancer Gold StandardTM accreditation for its ongoing commitment to...

December 15, 2020
Project Data Sphere

A manuscript published in December 2020 in Contemporary Clinical Trials Communications highlights work by Project Data Sphere and RTI International (RTI) to improve access to clinical trial data...

Spring 2020

K. Andrew Crighton, Chief Executive Officer, CEO Roundtable on Cancer
May 04, 2020
CEO Roundtable on Cancer

The CEO Roundtable on Cancer started 2020 with a new leadership team and a new vision to take the Roundtable and its programs to the next level.

K. Andrew Crighton, M.D....

Robert Ingram, Founding Chairman of the CEO Roundtable on Cancer
April 29, 2020
CEO Roundtable on Cancer

Robert A. Ingram, Founding Chairman of the CEO Roundtable on Cancer, has been appointed to the President’s Cancer Panel, which ...

COVID-19
April 09, 2020
CEO Roundtable on Cancer

COVID-19 immediately affected the conduct of ongoing clinical trials but it equally changed the way they will be conducted in the future, said speakers at the CEO Roundtable on Cancer online...

Project Data Sphere
April 29, 2020
Project Data Sphere

More than 2,400 researchers are using the Project Data Sphere® platform to answer important questions about cancer. Many of them have offered feedback on how we can make the platform even easier...

MaryLisabeth Rich
April 29, 2020
Gold Standard: Task Force

More than 200 employers are covering 7 million lives through CEO Cancer Gold Standard accreditation, an impressive population benefitting from increased cancer awareness, prevention and treatment...

CEO Roundtable on Cancer
April 29, 2020
CEO Roundtable on Cancer: In the News

BeiGene and John V. Oyler, Chairman, Co-Founder and CEO. BeiGene started in Beijing and has expanded to be a global company. Its focus is discovery, development, and...

All the Best Podcast
April 29, 2020
Gold Standard

At the CEO Roundtable on Cancer, we've come a long way in the 20 years since President George H.W. Bush urged us to do everything we could to defeat cancer.  One of the Bushes’ grandsons, Sam...

Anne Arundel Medical Center
April 13, 2020
Gold Standard

The CEO Roundtable on Cancer has accredited Anne Arundel Medical Center with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered...